Sucralfate Tablets USP 1 gram
Product details
- Sucralfate Tablets USP 1 gram
Company announcement
Nostrum Laboratories, Inc. is recalling Sucralfate Tablets USP 1 gram nationwide.
The recall is due to the company's closure and discontinuation of quality activities after filing for Chapter 11 bankruptcy on September 30, 2024.
The company can no longer guarantee the product meets specifications.
The recall affects all lots within expiry manufactured after June 2023.
No adverse events have been reported.
Risk:
The discontinuation of Nostrum Labs’ quality program means that the Company is unable to assure that this product meets the identity, strength, quality, and purity characteristics that it is purported or represented to possess. While specific risks to patients from use of an adulterated product cannot always be identified or assessed, it is also not possible to rule out patient risks resulting from the use of such a product.
Impacted states: Nationwide
Products:
- Sucralfate Tablets USP 1 gram
Contact
For more information, email recallcoordinator@nostrumlabsrecall.com.